VIROPHARMA
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. The company has two marketed products, and three development programs. The company markets and sells Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride, in the U.S. and its territories. Vancocin is a potent antibiotic approved by the U.S. Food and Drug Administration, or the FDA, to treat antibiotic-associated pseudomembranous colitis caused by Clostridium difficile infection (CDI), or C. difficile, and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
VIROPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1994-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.viropharma.com
Total Employee:
5001+
Status:
Closed
Contact:
+353 1 429 7700
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving SPF Amazon Microsoft Azure DNS Amazon Route 53 AWS Global Accelerator DMARC Proofpoint
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
OraPharma Inc. (acquired by JNJ)
OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health.
PhenoTech
PhenoTech a biotechnology company, engages in the discovery, development, and commercialization of reagents for diagnostic.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
QuatRx Pharmaceuticals
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds
Sygnis Pharma
SYGNIS Pharma AG, a specialty pharmaceutical company, engages in the research, development, and marketing of drugs for the treatment of
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-10-27 | DuoCort Pharma | DuoCort Pharma acquired by ViroPharma | N/A |
| 2010-05-28 | Auralis | Auralis acquired by ViroPharma | N/A |
| 2008-07-15 | Lev Pharmaceuticals | Lev Pharmaceuticals acquired by ViroPharma | 585.89 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - ViroPharma
Official Site Inspections
http://www.viropharma.com
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 13.248.133.121
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "ViroPharma"
ViroPharma - Wikipedia
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) … See moreSee details»
ViroPharma - Crunchbase Company Profile & Funding
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings.See details»
Shire To Acquire Viropharma In Strategic Move To Strengthen
Nov 11, 2013 · ViroPharma is a high growth, rare disease biopharmaceutical company, whose commercial product CINRYZE® (C1 esterase inhibitor [human]), is a leading brand for the …See details»
Shire acquisition of ViroPharma - Takeda
Please visit http://www.viropharma.com/products/cinryze.aspx for the full U.S. Prescribing Information; the prescribing information for other countries can be found at www.viropharma.com.See details»
ViroPharma Company Profile 2024: Valuation, Investors
Developer of biopharmaceutical products for diseases. The company is engaged in the design and development of biopharmaceutical products for diseases such as, enterocolitis, …See details»
ViroPharma - Products, Competitors, Financials, Employees, …
ViroPharma is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of …See details»
ViroPharma - Ben Franklin Technology Partners
ViroPharma is an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs.See details»
ViroPharma Inc. - The New York Times
ViroPharma, formerly struggling biotechnology company, is reaping financial windfall from Vancocin, only drug approved to treat Clostridium difficile, bacterium that kills thousands of …See details»
ViroPharma - M&A Summary, Ownership, and Business Overview
Nov 11, 2013 · ViroPharma, Inc. is a pharmaceutical company committed to the commercialization, development, and discovery of new antiviral medicines. What's Mergr? We …See details»
Shire buys US drugs group ViroPharma for $4.2bn - Financial Times
Nov 11, 2013 · Shire, the London-listed pharmaceuticals group, has moved to bolster its rare disease treatment business with the $4.2bn acquisition of ViroPharma.See details»
Shire buys ViroPharma in $4.2 billion deal | AP News
Nov 11, 2013 · LONDON (AP) — The drugmaker Shire PLC plans to strengthen its rare disease treatment portfolio by spending $4.2 billion in cash to buy the biopharmaceutical company …See details»
Shire of Ireland to Pay $4.2 Billion for U.S. Drug Maker
Nov 11, 2013 · LONDON — The Irish pharmaceutical company Shire has agreed to pay $4.2 billion in cash to acquire ViroPharma, a Pennsylvania biopharmaceutical firm, in a move …See details»
Shire boosts rare disease portfolio with acquisition of ViroPharma
Nov 11, 2013 · Shire is to acquire rare disease company ViroPharma for $4.2 billion in a strategic move to boost its orphan drug portfolio. ViroPharma is a high growth, rare disease biopharma …See details»
ViroPharma Incorporated Completes Acquisition Of Lev …
Oct 24, 2008 · ViroPharma Incorporated recently announced it has completed its acquisition of Lev Pharmaceuticals (BULLETIN BOARD: LEVP) following the approval earlier today of the …See details»
ViroPharma - Contacts, Employees, Board Members, Advisors
ViroPharma, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseasesSee details»
ViroPharma Company Information - Drugs.com
ViroPharma manufactures, markets and/or distributes more than 3 drugs in the United States. Medications listed here may also be marketed under different names in different countries. …See details»
ViroPharma To Acquire Lev Pharmaceuticals - Fierce Biotech
Jul 15, 2008 · Under the terms of the merger agreement, ViroPharma will acquire the outstanding common stock of Lev for $2.25 per share in cash and $0.50 per share in stock ("Upfront …See details»
Maribavir: First Approval | Drugs - Springer
Feb 11, 2022 · Maribavir (LIVTENCITY TM) is a cytomegalovirus (CMV) enzyme pUL97 kinase inhibitor being developed by Takeda Pharmaceuticals for the treatment of CMV infections. …See details»
ViroPharma Management Team - CB Insights
Explore {ViroPharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Health Canada Approves New Drug Submission for Cinryze
Oct 22, 2012 · ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to …See details»